نتایج جستجو برای: dlbcl

تعداد نتایج: 2906  

Journal: :iranian journal of pathology 2011
hamid tabrizchee armita esmaili

background and objectives: classic hodgkin lymphoma (chl), anaplastic large cell lymphoma (alcl) and some cases of diffuse large b cell lymphoma (dlbcl) have overlapping morphologic features. since they all represent distinct clinico-pathologic entities, we explored the differential diagnostic impact of immunophenotyping to discriminate between them. materials and methods: we included 61 cases ...

رضوان, ملیحه, کوثری, فرید, یاریگر روش, حمیدرضا,

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. There are various types of DLBCL including immunoblastic and centroblastic. Epstein-Barr virus (EBV) is a member of Herpes virus family found in all human populations inducing different lymphoproliferative disorders. The role of EBV in the development of DLBCL is known. Multiple laboratory methods are availab...

Alireza Sadeghipour Ardeshir Ghavamzadeh Farid Kosari, Kamran Alimoghaddam Naghmeh Amin Taheri

  Background and Objectives: Epstein Barr Virus (EBV) is one of the members of herpesviridae family and a sub-category of Gamma herpes virinae. EBV, which normally has CR2 or CD21 receptors on B-lymphocytes, has mutagenic features for them. The virus plays an important role in causing some malignant cancers. About 30% of the cases with non-Hodgkin’s lymphoma are diffuse large B-cell l...

Journal: :iranian journal of pathology 2011
farid kosari naghmeh amin taheri alireza sadeghipour kamran alimoghaddam ardeshir ghavamzadeh

background and objectives: epstein barr virus (ebv) is one of the members of herpesviridae family and a sub-category of gamma herpes virinae. ebv, which normally has cr2 or cd21 receptors on b-lymphocytes, has mutagenic features for them. the virus plays an important role in causing some malignant cancers. about 30% of the cases with non-hodgkin’s lymphoma are diffuse large b-cell lymphoma (dlb...

Armita Esmaili, Hamid Tabrizchee

  Background and Objectives: Classic Hodgkin lymphoma (CHL), anaplastic large cell lymphoma (ALCL) and some cases of diffuse large B cell lymphoma (DLBCL) have overlapping morphologic features. Since they all represent distinct clinico-pathologic entities, we explored the differential diagnostic impact of immunophenotyping to discriminate between them. Materials and Methods:...

2002
Motoko Yamaguchi Masao Seto Masataka Okamoto Ryo Ichinohasama Naoya Nakamura Tadashi Yoshino Junji Suzumiya Takuhei Murase Ikuo Miura Takashi Akasaka Jun-ichi Tamaru Ritsuro Suzuki Yoshitoyo Kagami Masami Hirano Yasuo Morishima Ryuzo Ueda Hiroshi Shiku Shigeo Nakamura

De novo CD5 diffuse large B-cell lymphoma (CD5 DLBCL) is known to have phenotypically and genotypically different characteristics than CD5 DLBCL and mantle cell lymphoma (MCL). To further characterize CD5 DLBCL, 109 patients with CD5 DLBCL were reviewed, and the results were compared with those of 384 CD5 DLBCL and 128 cyclin D1 MCL patients. Patients with CD5 DLBCL showed a higher age distribu...

2011
Julie Gonin Frédérique Larousserie Christian Bastard Jean-Michel Picquenot Jérôme Couturier Isabelle Radford-Weiss Céline Dietrich Nicole Brousse Marie-Cécile Vacher-Lavenu Odile Devergne

The distinction between Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL), two types of mature aggressive B-cell lymphomas that require distinct treatments, can be difficult because of forms showing features intermediate between DLBCL and BL (here called BL/DLBCL). They can be discriminated by the presence of c-myc translocations characteristic of BL. However, these are not exclus...

Journal: :Blood 2012
Mary Pulvino Yue Liang David Oleksyn Michael DeRan Elise Van Pelt Joel Shapiro Ignacio Sanz Luojing Chen Jiyong Zhao

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, remains a partially curable disease. Genetic alterations affecting components of NF-κB signaling pathways occur frequently in DLBCL. Almost all activated B cell-like (ABC) DLBCL, which is the least curable group among the 3 major subtypes of this malignancy, and a substantial fraction of germinal center B cell-...

2015
Xianping Shi Xiaoying Lan Xin Chen Chong Zhao Xiaofen Li Shouting Liu Hongbiao Huang Ningning Liu Dan Zang Yuning Liao Peiquan Zhang Xuejun Wang Jinbao Liu

Resistance to chemotherapy is a great challenge to improving the survival of patients with diffuse large B-cell lymphoma (DLBCL), especially those with activated B-cell-like DLBCL (ABC-DLBCL). Therefore it is urgent to search for novel agents for the treatment of DLBCL. Gambogic acid (GA), a small molecule derived from Chinese herb gamboges, has been approved for Phase II clinical trial for can...

2017
Hyun-Young Kim Mi-Ae Jang Hee-Jin Kim Seok Jin Kim Won Seog Kim Sun-Hee Kim

BACKGROUND CD5-positive diffuse large B-cell lymphoma (CD5+ DLBCL) accounts for 5-10% of DLBCL cases and has poor patient outcomes. However, most studies on CD5+ DLBCL were performed in Japanese patients and only few data are available for Korean population. In this study, we investigated the clinical characteristics and prognostic impact of CD5 expression in Korean patients with bone marrow (B...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید